FDA Office of the Chief Medical Officer Guidance Agenda | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2024-N-5427

FDA Office of the Chief Medical Officer Guidance Agenda

Documents

Comments

Description

OPEN

Comment Period OpensJan 13, 2025

Type	Title	Posted	Comments	Status
Other	OCMO Guidance Agenda (2026)	Apr 15, 2026	--

Total Comments

OCMO

FDA Office of the Chief Medical Officer

Guidance Agenda

OPEN